Centene (NYSE:CNC) Releases FY 2025 Earnings Guidance

Centene (NYSE:CNC - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 7.250- for the period, compared to the consensus estimate of 7.300. The company issued revenue guidance of -.

Centene Stock Performance

Shares of CNC stock traded up $1.72 during trading hours on Friday, reaching $61.78. The stock had a trading volume of 4,368,389 shares, compared to its average volume of 4,868,414. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The firm has a 50-day simple moving average of $60.66 and a 200-day simple moving average of $60.45. The firm has a market capitalization of $30.74 billion, a PE ratio of 9.90, a price-to-earnings-growth ratio of 0.80 and a beta of 0.48. Centene has a twelve month low of $55.03 and a twelve month high of $80.59.

Centene (NYSE:CNC - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $2.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.38. The firm had revenue of $46.62 billion during the quarter, compared to analyst estimates of $43.16 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. Centene's revenue was up 15.4% on a year-over-year basis. During the same period in the previous year, the business posted $2.26 EPS. As a group, equities analysts forecast that Centene will post 6.86 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on CNC shares. StockNews.com lowered shares of Centene from a "strong-buy" rating to a "buy" rating in a research note on Monday, April 28th. Guggenheim reissued a "neutral" rating on shares of Centene in a research note on Tuesday, April 29th. Argus lowered shares of Centene from a "buy" rating to a "hold" rating in a research note on Thursday, February 6th. Barclays reduced their price target on shares of Centene from $93.00 to $84.00 and set an "overweight" rating for the company in a research note on Monday, April 28th. Finally, Jefferies Financial Group reduced their price target on shares of Centene from $64.00 to $61.00 and set a "hold" rating for the company in a research note on Tuesday, April 29th. Seven analysts have rated the stock with a hold rating and ten have given a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $79.77.

Institutional Investors Weigh In On Centene

An institutional investor recently bought a new position in Centene stock. Baird Financial Group Inc. purchased a new stake in shares of Centene Co. (NYSE:CNC - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,883 shares of the company's stock, valued at approximately $236,000. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.